4.11. XOD Inhibition Assay

MY Masao Yamasaki
YK Yusei Kiue
KF Kento Fujii
MS Moe Sushida
YY Yumi Yamasaki
KS Kazuhiro Sugamoto
YS Yosuke Suzuki
YK Yasuko Koga
HK Hisato Kunitake
HK Hisahiro Kai
KO Kenjiro Ogawa
KN Kazuo Nishiyama
YG Yo Goto
TN Takayuki Nakayama
request Request a Protocol
ask Ask a question
Favorite

The direct inhibitory effect of BLEx and its fractions on XOD activity was evaluated as the conversion of xanthine to uric acid under XOD (from bovine milk, Sigma). Uric acid, xanthine, and allopurinol (Fujifilm Wako) were dissolved in 0.1 M phosphate buffer (PB; pH 8.0). Next, 50 μL PB, 50 μL samples (appropriate concentrations of BLEx, fractions, or 1 mM allopurinol), and 100 μL of 1 mM xanthine were added to a 96-well plate (UV-star, Greiner Bio-One, Kremsmünster, Austria). Finally, XOD was added to a final concentration at 0.1 mU and reacted for 3 min at 37 °C. The production of uric acid was measured as the absorbance at 293 nm using SpectraMax (Molecular Devices, San Jose, CA, USA).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A